Physician profile
Sangjin Oh
NPI 1316966179
$1,451,174.18
in general payments reported to CMS, 2019-2025
93 companies · $234K in 2025
The $234K reported for 2025 was more than what 99% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290K · 2020: $148K · 2021: $181K · 2022: $218K · 2023: $194K · 2024: $188K · 2025: $234K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $477K · Consulting Fee: $68K · Food and Beverage: $44K · Travel and Lodging: $23K · Honoraria: $1,600 · Education: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $477,327.25 |
| Consulting Fee | $68,144.47 |
| Food and Beverage | $44,355.18 |
| Travel and Lodging | $23,316.33 |
| Honoraria | $1,600.00 |
| Education | $368.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $333,372.79 | 2019-2025 | Mavenclad, Mavenclad |
| Biogen, INC. | $176,109.24 | 2019-2025 | Vumerity, Tysabri, Tysabri |
| Tg Therapeutics, INC. | $150,091.31 | 2023-2025 | Briumvi |
| E.R. Squibb & Sons, L.L.C. | $147,248.54 | 2020-2025 | Zeposia |
| Amgen INC. | $127,541.53 | 2019-2025 | Uplizna, Aimovig |
| Genzyme Corporation | $87,641.14 | 2019-2025 | |
| Abbvie INC. | $67,037.20 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $59,338.31 | 2019-2025 | Kesimpta |
| Celgene Corporation | $52,866.41 | 2019-2025 | Zeposia |
| Teva Pharmaceuticals USA, INC. | $41,692.15 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
| Genentech USA, INC. | $30,077.35 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Vanda Pharmaceuticals INC. | $29,558.01 | 2022-2025 | Ponvory |
| Lilly USA, LLC | $19,383.07 | 2019-2025 | Kisunla, Emgality, Reyvow |
| Biohaven Pharmaceuticals, INC. | $18,194.71 | 2021 | |
| Banner Life Sciences, LLC | $16,105.02 | 2021-2024 |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $15,805.65 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $14,014.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $13,145.66 | 2020-2023 | Ponvory |
| Avanir Pharmaceuticals, INC. | $7,736.88 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $5,402.01 | 2019 | |
| Horizon Therapeutics Plc | $4,870.58 | 2021-2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $3,945.12 | 2020-2024 | Acthar |
| Lundbeck LLC | $2,236.87 | 2020-2025 | Vyepti |
| Pfizer INC. | $1,811.07 | 2019-2025 | |
| Harmony Biosciences LLC | $1,755.08 | 2020-2025 | Wakix |
| Ucb, INC. | $1,714.77 | 2019-2025 | Briviact, Rystiggo, Zilbrysq |
| Livanova USA, INC. | $1,554.82 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| F. Hoffmann-La Roche Ag | $1,500.00 | 2021 | |
| Janssen Scientific Affairs, LLC | $1,362.50 | 2024 | |
| Eisai INC. | $1,329.51 | 2019-2025 | |
| Ani Pharmaceuticals, INC. | $1,175.00 | 2021 | |
| Alexion Pharmaceuticals, INC. | $1,165.36 | 2019-2025 | Ultomiris, Soliris |
| Cycle Pharmaceuticals INC | $1,047.52 | 2023-2025 | Bafiertam, Tascenso Odt |
| Sunovion Pharmaceuticals INC. | $903.66 | 2019-2022 | |
| Argenx US, INC. | $847.87 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Neurocrine Biosciences, INC. | $782.36 | 2020-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $767.15 | 2021-2025 | Valtoco |
| Jazz Pharmaceuticals INC. | $702.39 | 2019-2024 | |
| Akcea Therapeutics, INC. | $650.89 | 2020-2021 | |
| Grifols USA, LLC | $605.28 | 2019-2025 | Gamunex-C, Xembify |
| Amneal Pharmaceuticals LLC | $589.99 | 2019-2025 | Crexont, Rytary, Lyvispah |
| Acadia Pharmaceuticals INC | $560.11 | 2019-2025 | Nuplazid, Daybue |
| Csl Behring | $447.17 | 2019-2025 | Hizentra |
| Axsome Therapeutics, INC. | $441.89 | 2023-2025 | Sunosi, Symbravo |
| Sumitomo Pharma America, INC. | $418.00 | 2023-2024 | Aptiom |
| Sk Life Science, INC. | $382.13 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $379.35 | 2020-2025 | Hyqvia, Gammagard |
| Catalyst Pharmaceuticals, INC. | $371.84 | 2023-2024 | Fycompa |
| Octapharma USA, INC. | $335.34 | 2023-2025 | Panzyga |
| Otsuka America Pharmaceutical, INC. | $316.67 | 2022-2025 | Rexulti, Nuedexta |
| Greenwich Biosciences, INC. | $280.15 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $276.55 | 2019-2022 | |
| Kyowa Kirin, INC. | $255.37 | 2020-2024 | Nourianz |
| Janssen Biotech, INC. | $254.61 | 2025 | |
| Alnylam Pharmaceuticals INC. | $239.19 | 2020-2025 | Amvuttra |
| Mdd US Operations, LLC | $233.36 | 2019-2024 | Gocovri, Gocovri |
| Tanabe Pharma America, INC. | $203.75 | 2019-2025 | Radicava |
| Merck Sharp & Dohme LLC | $195.91 | 2020-2023 | Belsomra |
| Acorda Therapeutics, INC | $176.75 | 2019-2024 | Inbrija, Ampyra |
| Noctrix Health, INC. | $164.48 | 2025 | Nidra |
| Adamas Pharmaceuticals, INC. | $160.97 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $160.66 | 2019-2022 | |
| Kedrion Biopharma, INC. | $116.76 | 2025 | Albuked, Rhogam Ultra-Filtered Plus, Gammaked |
| Ge Healthcare | $106.48 | 2019-2020 | |
| Azurity Pharmaceuticals, INC. | $87.03 | 2023-2025 | Horizant, Azmiro, Zonisade |
| Novo Nordisk INC | $82.38 | 2019 | |
| Impel Pharmaceuticals INC. | $75.11 | 2023 | Trudhesa |
| Almatica Pharma LLC | $64.90 | 2021-2023 | Gralise |
| Idorsia Pharmaceuticals US INC | $62.66 | 2023-2024 | Quviviq |
| Nevro Corp. | $55.30 | 2024 | Senza |
| Globus Medical, INC. | $53.19 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $45.42 | 2022 | |
| Currax Pharmaceuticals LLC | $42.58 | 2020-2025 | Onzetra Xsail |
| Avion Pharmaceuticals | $37.31 | 2022 | |
| Cala Health, INC. | $35.79 | 2022-2023 | Cala Trio |
| Arbor Pharmaceuticals, INC. | $34.89 | 2019-2022 | |
| Impel Pharmaceuticals LLC | $33.46 | 2024-2025 | Trudhesa |
| Abbott Laboratories | $27.53 | 2021 | |
| Averitas Pharma INC. | $26.49 | 2025 | Qutenza |
| Inspire Medical Systems, INC. | $25.61 | 2025 | Inspire |
| Life Molecular Imaging Ltd | $24.89 | 2025 | Neuraceq |
| Merz Pharmaceuticals, LLC | $23.98 | 2024 | Ampyra |
| Insightec,INC | $22.73 | 2025 | Exablate |
| Scilex Pharmaceuticals INC. | $20.91 | 2024 | |
| Vertical Pharmaceuticals, LLC | $20.25 | 2019 | |
| Shire North American Group INC | $18.78 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.40 | 2019 | |
| Resmed Corp | $16.93 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $15.73 | 2025 | Lumryz |
| Aquestive Therapeutics, INC. | $15.29 | 2020 | |
| Promius Pharma LLC | $12.85 | 2019 | |
| Medtronic USA, INC. | $12.14 | 2020 | |
| Genentech, INC. | $5.61 | 2022 |
Drugs and devices associated with these payments
Mavenclad $184KBriumvi $150KZeposia $67KVumerity $40KPonvory $30KUbrelvy $29KQulipta $17KBafiertam $12KUplizna $12KKisunla $11KOcrevus $7,448Tysabri $6,749Kesimpta $3,463Vyepti $2,087Nurtec Odt $1,584Wakix $1,156Nityr $870Valtoco $657Ingrezza $612Mayzent $576Zavzpret $561Briviact $546Leqembi $525Panzyga $489Austedo Xr $459Nuplazid $450Fycompa $438Ocrevus Zunovo $437Vyvgart Hytrulo $424Aptiom $418Sunosi $413Ultomiris $390Epidiolex $375Emgality $367Crexont $344Vyvgart $335Reyvow $314Hizentra $272Duopa $261Aimovig $178Rexulti $175Nidra $164Comirnaty $157Gocovri $153Gamunex-C $152Paxlovid $141Vraylar $139Ongentys $138Rytary $136Octagam Immune Globulin (Human) $133Hyqvia $129Austedo $128Nuedexta $121Amyvid $117Koate $117Kedrab $117Albuked $117Rhogam Ultra-Filtered Plus $117Gammaked $117Vyalev $117Trudhesa $109Senza $108Rystiggo $108Vns Therapy Sentiva Model 1000 Generator $105Zilbrysq $101Radicava $96.02Nayzilam $90.15Belsomra $86.41Nourianz $72.77Radicava Ors $72.69Aubagio $69.04Quviviq $62.66Cutaquig $52.42Zepbound $49.91Acthar $49.78Lyvispah $46.51Ampyra $44.70Amvuttra $44.03Gammagard $43.95Plegridy $43.07Tascenso Odt $42.41Fintepla $40.85Horizant $40.47Soliris $40.13Symbravo $28.68Qutenza $26.49Inspire $25.61Neuraceq $24.89Azmiro $23.99Xembify $22.90Exablate $22.73Gralise $22.70Zonisade $22.57Daybue $21.07Ztlido $20.91Inbrija $20.72Xywav $19.24Lumryz $15.73Onzetra Xsail $14.48Ongentys 50mg Capsules 30 $13.22
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sangjin Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.